...
首页> 外文期刊>Toxicological sciences: An official journal of the Society of Toxicology >Airway Tissue Plasminogen Activator Prevents Acute Mortality Due to Lethal Sulfur Mustard Inhalation
【24h】

Airway Tissue Plasminogen Activator Prevents Acute Mortality Due to Lethal Sulfur Mustard Inhalation

机译:气道组织中的纤溶酶原激活剂可防止因吸入致命性硫芥菜而导致的急性死亡

获取原文
获取原文并翻译 | 示例

摘要

Rationale: Sulfur mustard (SM) is a chemical weapon stockpiled today in volatile regions of the world. SM inhalation causes a life-threatening airway injury characterized by airway obstruction from fibrin casts, which can lead to respiratory failure and death. Mortality in those requiring intubation is more than 80%. No therapy exists to prevent mortality after SM exposure. Our previous work using the less toxic analog of SM, 2-chloroethyl ethyl sulfide, identified tissue plasminogen activator (tPA) an effective rescue therapy for airway cast obstruction (Veress, L. A., Hendry-Hofer, T. B., Loader, J. E., Rioux, J. S., Garlick, R. B., and White, C. W. (2013). Tissue plasminogen activator prevents mortality from sulfur mustard analog-induced airway obstruction. Am. J. Respir. Cell Mol. Biol. 48, 439-447). It is not known if exposure to neat SM vapor, the primary agent used in chemical warfare, will also cause death due to airway casts, and if tPA could be used to improve outcome. Methods: Adult rats were exposed to SM, and when oxygen saturation reached less than 85% (median: 6.5 h), intratracheal tPA or placebo was given under isoflurane anesthesia every 4 h for 48 h. Oxygen saturation, clinical distress, and arterial blood gases were assessed. Microdissection was done to assess airway obstruction by casts. Results: Intratracheal tPA treatment eliminated mortality (0% at 48 h) and greatly improved morbidity after lethal SM inhalation (100% death in controls). tPA normalized SM-associated hypoxemia, hypercarbia, and lactic acidosis, and improved respiratory distress. Moreover, tPA treatment resulted in greatly diminished airway casts, preventing respiratory failure from airway obstruction. Conclusions: tPA given via airway more than 6 h after exposure prevented death from lethal SM inhalation, and normalized oxygenation and ventilation defects, thereby rescuing from respiratory distress and failure. Intra-airway tPA should be considered as a life-saving rescue therapy after a significant SM inhalation exposure incident.
机译:理由:芥菜(SM)是当今在世界动荡地区储存的化学武器。吸入SM会导致威胁生命的气道伤害,其特征是纤维蛋白铸模阻塞气道,从而导致呼吸衰竭和死亡。需要插管的人的死亡率超过80%。目前尚无任何疗法可预防SM暴露后的死亡。我们以前的研究使用毒性较小的SM类似物2-氯乙基乙基硫醚,确定了组织纤溶酶原激活剂(tPA),这是一种有效的抢救性治疗气道铸件阻塞的方法(Veress,LA,Hendry-Hofer,TB,Loader,JE,Rioux,JS ,Garlick,RB和White,CW(2013)。组织纤维蛋白溶酶原激活剂可防止硫芥子类似物诱导的气道阻塞致死(美国血液呼吸杂志,第48卷,第439-447页)。目前尚不清楚是否会暴露于化学战中使用的主要化学试剂纯净SM蒸气是否还会因气道铸模而导致死亡,以及是否可以使用tPA改善结局。方法:成年大鼠暴露于SM,当血氧饱和度低于85%(中位数:6.5 h)时,每4 h在异氟烷麻醉下给予气管内tPA或安慰剂48 h。评估血氧饱和度,临床窘迫和动脉血气。进行显微解剖以评估演员的气道阻塞。结果:气管内tPA治疗消除了死亡率(48小时时为0%),并大大提高了致死性SM吸入后的发病率(对照组为100%死亡)。 tPA使SM相关的低氧血症,高碳酸血症和乳酸性酸中毒正常化,并改善了呼吸窘迫。此外,tPA治疗可大大减少气道铸型,防止因气道阻塞而导致呼吸衰竭。结论:暴露后6小时以上通过气道给予tPA可以防止致命的SM吸入死亡,正常的氧合和通气缺陷,从而避免呼吸窘迫和衰竭。在发生严重的SM吸入暴露事件后,应将气管内tPA视为挽救生命的挽救疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号